Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazen Issa

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Inflammatory Bowel Diseases|May 23, 2009
Durability of infliximab in Crohn's disease: a single-center experienceJason E Gonzaga, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|July 29, 2009
Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?Ashwin N Ananthakrishnan, Dawn B Beaulieu, Alex Ulitsky, et al.
Frontiers in Medicine|December 17, 2024
Corneal stromal mapping characteristics in normal corneas using anterior segment SD-OCTMohammad Abusamak, Sara Mazen Issa, Amal F Alomari, et al.
Inflammatory Bowel Diseases|August 6, 2008
History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitisAshwin N Ananthakrishnan, Mazen Issa, Dawn B Beaulieu, et al.
Inflammatory Bowel Diseases|August 6, 2008
Budesonide induction and maintenance therapy for Crohn's disease during pregnancyDawn B Beaulieu, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|November 20, 2009
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's diseaseDaniel J Stein, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|February 26, 2011
Clinical course of Crohn's disease following treatment of lymphomaMarwa El Mourabet, Jana G Hashash, Nicholas H Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2007
Impact of Clostridium difficile on inflammatory bowel diseaseMazen Issa, Aravind Vijayapal, Mary Beth Graham, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Inflammatory Bowel Diseases|May 23, 2009
Durability of infliximab in Crohn's disease: a single-center experienceJason E Gonzaga, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|July 29, 2009
Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?Ashwin N Ananthakrishnan, Dawn B Beaulieu, Alex Ulitsky, et al.
Frontiers in Medicine|December 17, 2024
Corneal stromal mapping characteristics in normal corneas using anterior segment SD-OCTMohammad Abusamak, Sara Mazen Issa, Amal F Alomari, et al.
Inflammatory Bowel Diseases|August 6, 2008
History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitisAshwin N Ananthakrishnan, Mazen Issa, Dawn B Beaulieu, et al.
Inflammatory Bowel Diseases|August 6, 2008
Budesonide induction and maintenance therapy for Crohn's disease during pregnancyDawn B Beaulieu, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|November 20, 2009
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's diseaseDaniel J Stein, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|February 26, 2011
Clinical course of Crohn's disease following treatment of lymphomaMarwa El Mourabet, Jana G Hashash, Nicholas H Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2007
Impact of Clostridium difficile on inflammatory bowel diseaseMazen Issa, Aravind Vijayapal, Mary Beth Graham, et al.
Pageof 2